(/ > = 0.009). Blood pressure correlated significantly with indices of LV hypertrophy in the recent group. Systolic function was normal in both groups but diastolic function was disturbed in both and to the same extent, atrial systole contributing by 27+14% to ventricular filling. Conclusion. Better treatment of hypertension, fluid overload, and uraemia has led to less pronounced LV hypertrophy. The remaining correlation with blood pressure suggests that more could be gained by intensified antihypertensive treatment.
Introduction
Echocardiographic studies in patients with type 1 diabetes reveal abnormalities in myocardial function. The usual finding is a hypertrophic left ventricle (LV) with normal or only slightly reduced systolic function but abnormal diastolic filling properties [1] [2] [3] . This is most pronounced in patients with long duration and secondary complications such as hypertension, renal failure, anaemia, autonomic neuropathy and ischaemic heart disease [2, [4] [5] [6] [7] .
Treatment of patients with diabetic nephropathy has been intensified during the last 10 years with respect to control of hyperglycaemia, oedema, blood pressure, anaemia, and uraemia. The aim of our study was to describe possible effects of such therapeutic progress on cardiac function in patients with end-stage renal disease.
Subjects and methods

Patients
Patients with type 1 diabetes and end-stage renal disease were investigated in 1991-1993 (recent group), and the results compared with those from a similar group investigated in 1977-1980 (early group). The patients were referred from all parts of the country. The early group, which has previously been reported [8] , were candidates for kidney transplantation while the recent group were candidates for combined kidney and pancreas transplantation. Acceptance was based on similar criteria in the two groups. Manifestiations of macroangiopathy and a debilitated condition were relative or absolute contraindications, depending on severity, whereas blindness or severe neuropathy were not. An exercise test was required but was in most cases limited by non-cardiac symptoms. In the majority of patients, coronary angiograms were not performed. In retrospect, applying today's criteria, without knowledge of the results of the echocardiographic investigations, 22 of 27 patients investigated in the early period were judged eligible for simultaneous pancreas and kidney transplantation, while 23 of 26 patients in the recent group were actually accepted for this procedure.
Our healthy control group consists of 20 male and 9 female individuals without hypertension, diabetes or any history of heart disease. For each group of patients normal controls were selected to match as closely as possible for number and sex distribution. The male controls were investigated in the same period as the early group, while the female controls were investigated in 1993.
Blood pressure and glycaemic control
Blood pressure was measured with a sphygomanometer after at least 5 min supine rest, the Korotkoff phase 1 and 5 sounds indicating systolic and diastolic pressure respectively. The blood pressure observer was unaware of the results of the echocardiographic investigation. The echocardiographic investigator was not aware of the result of blood pressure measurement. Long-term glycaemic control was assessed in the recent group by glycated haemoglobin, HbA lc , at the time of the echocardiographic investigation. Upper limit of normal is 5.4%.
Echocardiography
Echocardiography was performed with the patient in a left lateral position. An Acuson 128 was used to examine the recent group. The investigation included two-dimensional and M-mode echocardiography, as well as colour-, pulsed-, and continuous wave Doppler. Measurements were made according to recommondations of the American Heart Association [9] . M-mode measurement of left ventricular end diastolic diameter (LVDr), thickness of the interventricular septum (IVS) and thickness of posterior wall (LVPW) was done at the peak of the R-wave in the ECG. Measurement of left ventricular diameter just before atrial filling (LVDp) was done at the peak of the P-wave. Mitral inflow velocites, the peak flow velocity in early filling (E) and the peak flow velocity in atrial systole (A) were measured with pulsed Doppler. The upper normal limit for A/E ratio is 1.0. The mean of three cardiac cycles was used. The early group of patients were investigated using an Echoscan 30 (Mediscan, Copenhagen, Denmark) and only M-mode echocardiography was performed.
Definitions
Body surface area. (BSA) was defined as B S A = l + ( b o d y weight-I-height-160)/100. LVmass was calculated using the cube formula on the ellipsoid model [10] . Calculations are based on the assumption that the left ventricle may be geometrically represented as a prolate ellipsoid of volume (V) given by the formula:
where L is the long axis and D, and D 2 are short axes. Echocardiographic LV mass (g) was estimated by subtracting the volume of the cavity from that of the total ventricle and multiplying with 1.05 which is the specific gravity of heart muscle. 
Statistics
Differences between the groups were calculated using the non-parametric Mann-Whitney U test, and for proportions O. Bech-Hanssen el al.
the Chi-square test. Results are shown as mean + 1 SD and significance was taken to be P<0.05. A multivariate regression analysis was performed with LV mass index as dependent variable and systolic blood pressure, gender, age, duration of diabetes, haemoglobin, and early versus recent group as independent variables. Table 1 shows how the groups compare in various demographic and clinical aspects. Age at onset of diabetes was the same in the two groups but patients in the recent group were 3 years older at the time of investigation and had thus had 3 years longer duration of disease. About half of the patients in the recent group had started dialysis at the time of evaluation but only six of 27 in the early group. Median duration of dialysis was short in both groups, 3, 1-9 months (median, range) versus 1.5, 0.5-8.5 months, / > =0.08. Serum creatinine values at the time when dialysis was initiated was significantly lower in the recent group and those who were predialytic in the recent group had significantly lower serum creatinine values.
Results
Clinical data
Supine resting blood pressure was significantly lower in the recent group. The reduction was more pronounced in women (systolic pressure 175 mmHg versus 144mmHg in the early group, P = 0.01). The antihypertensive treatment in the early and recent group differed. In the recent group 62% were treated with ACE inhibition and the same proportion with calciumchannel blockers. These drugs were not used by the patients investigated in [1978] [1979] [1980] . No individuals in the recent group were treated with hydralazine, compared with 48% in the early group.
Echocardiography
The results of the echocardiographic investigations are shown in Table 2 . The left ventricle was significantly enlarged in the early group. In the absence of systolic dysfunction this indicates hypervolaemia. In contrast, no increase in LV systolic or diastolic diameter indices was found in the recent group.
Wall thickness was increased in both groups but this was less prominent in the recent group. Relative wall thickness was significantly increased in both early and recent group showing that the hypertrophy pattern is concentric. There were no subjects with eccentric hypertrophy.
LV mass index was significantly lower in the recent group. Figure 1 shows values for men and women separately. In the early group the degree of hypertrophy was similar for men and women. Comparison between the groups shows lower LV mass index for both women and men in the recent group but the difference was significant only for women (P = 0.04).
Overall systolic function was normal in both groups. Systolic dysfunction with reduced fractional shortening was found in four individual patients in the early group and six in the recent group. Diastolic function was Reduced LV hypertrophy in diabetic patients with ESRF disturbed in both groups and to a similar extent as judged by left atrium size and the contribution of atrial systole to LV filling. Doppler investigations in the recent group confirmed an increased ratio of atrial to early (A/E) LV filling velocity compared with healthy female controls. In the recent group, LV mass index, septal and LV posterior wall thickness showed strong correlations with systolic pressure (Table 3, Figure 2 ). In the early group a weak correlation between mass index and systolic blood pressure (r = 0.43, / > =0.03) was obtained only by exclusion of an outlier. Multiple regression analysis demonstrated systolic BT as a independent predictor of LV mass index (r 2 = 0.41). Gender, age, duration of diabetes, haemoglobin, and early vs recent group did not contribute significantly to the regression model. Glycaemic control (HbA lc ) in the recent group was not related to LV mass.
Systolic function LVFS (%)
Left ventricular mass
Discussion
A major question in the design of this study is whether the recent and early groups of patients are comparable.
1977-80
1991-93 Controls They had been selected from larger populations, as being candidates for kidney transplantation in the early era and for combined kidney and pancreas in the recent era. Strict criteria for referral were not defined, but the best suited candidates were certainly referred, and in addition some borderline cases. The proportion judged acceptable for pancreas transplantation was not different. Mean age at onset of diabetes was the same in both groups and the number of patients investigated per year was similar in the two periods. The recorded differences in echocardiographic variables therefore mainly reflect improvements in time.
Even though we consider the groups comparable in the sense that they are representative there are several clinical differences. These probably reflect the changes in treatment policies that gradually took place in the interval. Age at onset of diabetes was the same in both groups but patients in the recent group were older, and thus had had a slower progression of nephropathy. More patients in the recent group received dialysis, but this had been initiated at lower serum creatinine values. Patients who were not treated with dialysis had lower serum creatinine values than those in the early group. Patients in the recent group also had lower blood pressure values and received a higher number of antihypertensive drugs. ACE inhibitors were taken by 62% versus none. Furthermore, there was a trend for higher haemoglobin values, partly due to the use of erythropoietin. Long-term glycaemic control as assessed by HbA lc was fair. This test was not available for the early group, but our experience is that when testing was initiated, values of HbA lc dropped.
All this shows that the recent group received better treatment for hypertension and uraemia, and probably also for diabetes and anaemia. It is not possible to evaluate and describe how these improvements occurred over time in both groups of patients. In particular, for patients in the early group antihypertensive therapy was often initiated late. Their blood pressure as reported at the time of investigation therefore reflects the long-term load poorly. In reality, therefore, figures probably underestimate the differences between the groups.
Another matter of concern with our study design is whether the echocardiographic investigations from 
1977-1980 can be compared with recent investigations.
Since 1977 echocardiography has developed with new options such as two-dimensional imaging and flow velocity recordings (Doppler). However, in this study we compare parameters obtained by M-mode recordings and this technology has not improved to an extent which makes comparison unjustifiable. In both periods the measurements were made according to recommendations of the American Heart Association [9] . One of the authors (IW) was responsible for the measurements in the early study and also evaluated the recordings and measurements done in the recent group. The echocardiographic study showed that patients investigated in 1991-1993 had significantly less LV hypertrophy than patients investigated in 1977-1980. They had no signs of hypervolaemia, while the early group showed significantly increased diastolic and systolic volumes compared with healthy controls. Relative wall thickness was also increased as in the early group. This is a typical finding when the left ventricle is pressure overloaded.
Echocardiographic as well as histological and epidemiological studies give some support to the concept of diabetic cardiornyopathy or a diabetic specific heart muscle disorder [2, [11] [12] [13] . However, the rather good correlation of blood pressure with LV mass in the recent study group combined with an absence of correlations with age, duration of diabetes, and HbA l c suggests that blood pressure plays the major pathophysiological role in diabetic patients with end-stage renal disease. The multiple regression analysis demonstrated systolic BT to be the only independent predictor of LV mass index in the combined groups. The partial reversibility of pathological findings in the early group following renal transplantation also points towards fluid overload and hypertension as important pathophysiological factors [8] .
In both groups the blood pressure evaluated was taken at a single occasion. By increasing the number of measurements we would probably have obtained a better description of the actual pressure burden. Unfortunately this was not possible in the 'historical' early group. In spite of this fact we found a good correlation between systolic blood pressure and estimates of LV hypertrophy in the recent group. Systolic blood pressure explained 38% of the variation in mass index. In non-diabetic patients with hypertension, other studies show no or only weak correlations between pressure and LV hypertrophy [14] . Findings in type 1 diabetic patients by Thuesen et al. [15] agree with our result. However, our patients had longer duration of diabetes and more pronounced complications. Other contributors to hypertrophy, such as hyperglycaemia, uraemia, and anaemia might then have disturbed any existing correlation between pressure and LV mass. In the early group the correlation was weaker and this may be the result of such interference. Alternatively, less stable control of oedema and blood pressure, as discussed above, may have made actual blood pressure at the time of investigation a poorer estimate of their 1551 pressure burden in the past. Severe LV dysfunction with forward failure and reduced blood pressure is a possible confounder of relationship blood pressure and LV mass index. In our study the number of patients with severely reduced LV systolic function was small and therefore this is not an important confounder.
LV hypertrophy is a powerful independent predictor of cardiovascular morbidity in hypertensive patients without diabetes [16] . A prospective study by Koch et al. suggests that this is not the case in diabetic uraemic patients [17] , but effects of intervention may have confounded the result. In a recent study, Foley et al. [18] , evaluating patients starting renal replacement therapy, found that both diabetes and LV hypertrophy strongly increase the late mortality risk. However, the combination of these risk factors was not evaluated.
We could not demonstrate any improvement in diastolic function in the recent group, i.e. atrial contribution was not reduced. Our M-mode method can probably not detect all changes in diastolic filling properties. This requires a combination of several noninvasive methods [8, 12] . Furthermore, several other contributors to diastolic dysfunction such as silent ischaemic heart disease, uraemia, and diabetes per se remain [12, 19] . An investigation of kidney-transplant diabetic patients with and without a pancreas transplant showed less diastolic dysfunction in the group with a pancreas-transplant [20] .
Whether any of the abnormalities recorded bears an impact on outcome of transplantation remains uncertain. This cannot be evaluated based on the comparison between the recent and early groups because transplantations policies have been fundamentally changed by other influences, e.g. by the introduction of cyclosporin. The patients in the recent group will be followed after transplantation with respect to outcome and with new echocardiographic investigations. Hopefully this will add valuable information to the aspect of prognosis.
Our patients have had some benefit of the progress in treatment of diabetic nephropathy during the last decade, but the fact that they became uraemic shows that this was incomplete. The correlation between LV hypertrophy and blood pressure gives reason to believe that further improved treatment of hypertension would further reduce LV hypertrophy. Such improvement has probably already taken place for patients who developed diabetic nephropathy later than those now evaluated for transplantation. Many of them have received early and vigorous control of hypertension, often with ACE inhibitors which may prove especially beneficial for cardiac function. The outlook is therefore even better than shown in this study.
